Innocan Pharma Completes Additional Debenture Offering with Major Shareholder Innocan Pharma Corporation announces the successful closure of an additional debenture with its largest shareholder, Tamar Innovest, for $200,000.

Innocan Pharma Completes Additional Debenture Offering with Major Shareholder #Israel #Innocan_Pharma #Herzliya #Tamar_Innovest #Debenture

Innocan Pharma Moves Forward with Significant Debenture Offering to Tamar Innovest Innocan Pharma announces a new debenture offering to Tamar Innovest, aiming for $200,000 in funding while bolstering its corporate structure.

Innocan Pharma Moves Forward with Significant Debenture Offering to Tamar Innovest #Innocan_Pharma #Tamar_Innovest #Debenture_Offering

Innocan Pharma Completes Debenture Offering to Tamar Innovest for Continued Growth Innocan Pharma has successfully closed a debenture deal with its main shareholder, Tamar Innovest. The funding of $450,000 is aimed at enhancing corporate operations and supporting its NYSE listing.

Innocan Pharma Completes Debenture Offering to Tamar Innovest for Continued Growth #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture

Innocan Pharma Announces Significant Debenture Offering to Major Shareholder Tamar Innovest Innocan Pharma is set to offer a debenture to Tamar Innovest, its largest shareholder, aiming to raise $450,000 with a 10% interest rate. This move supports the company’s capital and growth.

Innocan Pharma Announces Significant Debenture Offering to Major Shareholder Tamar Innovest #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture

Innocan Pharma Concludes Significant Debenture Unit Offering with Tamar Innovest Limited Innocan Pharma has finalized a $1 million debenture unit offering to its primary shareholder, Tamar Innovest, enhancing its funding and growth prospects.

Innocan Pharma Concludes Significant Debenture Unit Offering with Tamar Innovest Limited #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture_Offering

Innocan Pharma Seeks $1 Million from Tamar Innovest via Debenture Unit Offering Innocan Pharma Corporation has announced a private placement of a debenture unit targeting Tamar Innovest, aiming to raise $1 million for corporate needs.

Innocan Pharma Seeks $1 Million from Tamar Innovest via Debenture Unit Offering #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture_Offering